Abstract
We report a case of reversible sensineural hearing loss due to hydroxychloroquine (HQ) treatment. The patient was a 34-year-old woman with 1 year of rheumatoid arthritis (RA). She developed reversible hearing loss after 5 months of HQ treatment. Sensineural deafness has previously been reported with chloroquine treatment, but this is the first report of ototoxicity associated with HQ in RA.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 6 March 2000 / Accepted 9 May 2000
Rights and permissions
About this article
Cite this article
Seçkin, Ü., Özoran, K., Ikinciogullari, A. et al. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatology International 19, 203–204 (2000). https://doi.org/10.1007/s002960000054
Issue Date:
DOI: https://doi.org/10.1007/s002960000054